The future of medicine is digital. The time of the international medical trade fair Medica in Germany, where manufacturers presented their innovations and market trends, has just come to an end. Today’s innovations, which were shown and discussed, tomorrow are bound to become a new standard in many countries. Hall 15 seems to have been especially interesting, including stalls with IT, data, telemedicine and so called digital health.
Over $200b, this is an amount that the digital health market is to be worth by 2020, according to an assessment presented in “Digital and Disrupted: All Change for Healthcare” report by Roland Berger, an advisory company. Today, the value amounts to about $80b, which means that medicine is going to see a great leap in this respect. This direction of development was quite visible during the Medica trade fair. The propositions of many manufacturers of medical devices one could summarize in a short phrase: more and more screens of mobile devices and tablets, and fewer and fewer wires and cables. It is not going to change in the coming years. In their report, Roland Berger’s experts forecast that the share of wireless and mobile solutions in health care will rise markedly faster than the share of traditional solutions, on average at the rate of 23% and 41% respectively.
In Germany, also Polish companies would not have missed the opportunity to present their solutions. One of the companies that presented its telemedical solutions was Nestmedic, a manufacturer of the mobile CTG Pregnabit device. The device that is designed to monitor the fetal well-being aligns with the latest trends. It allows to reliably monitor the fetal and maternal heart rates, and the record of the uterine contraction activity. It is a portable device, so the examination can be carried out at any time and in any place. The data collected with the device are transferred wireless to the Telemonitoring Medical Center managed by medical personnel.
– Apparently, for patients and physicians mobility and better prevention is not only a vision of the future but a concrete need and more and more often a new normal,
says Patrycja Wizińska-Socha, MD PhD, the proponent of the mobile CTG Pregnabit device and the CEO of Nestmedic.
